News

We invest in growth stage diagnostic companies and empower them with the full strength of our collective resources, capital, and expertise.

September 8, 2022

Sapphiros Acquires Flexotronix Limited

September 6, 2022

Mike Musgnug Joins Sapphiros as Executive Vice President, Strategy and CEO, GrapheneDx

August 23, 2022

Satio and Institut Pasteur de Dakar Form Strategic Partnership on Research, Development, Manufacture, and Distribution of Next Generation Healthcare Technologies

August 23, 2022

Satio and INTACT Form Strategic Partnership to Jointly Improve Delivery of Mass Vaccination

Sapphiros, a Next-Generation Diagnostics Platform, Announces Executive Appointments

Gates Foundation backs Biocrucible’s COVID-19 venture